USANA Health Sciences Files Proxy Materials

Ticker: USNA · Form: DEFA14A · Filed: 2024-03-27T00:00:00.000Z

Sentiment: neutral

Topics: proxy-statement, corporate-governance

TL;DR

USANA Health Sciences filed proxy docs, nothing new for traders.

AI Summary

USANA Health Sciences, Inc. filed a Definitive Additional Materials (DEFA14A) on March 27, 2024. This filing is related to their proxy statement and indicates no fee was required for this submission. The company is incorporated in Utah and operates in the medicinal chemicals and botanical products sector.

Why It Matters

This filing is a routine part of corporate governance, providing shareholders with information related to voting and company matters.

Risk Assessment

Risk Level: low — This is a routine filing related to proxy statements and corporate governance, not indicating any immediate financial or operational risks.

Key Players & Entities

FAQ

What type of SEC filing is this?

This is a DEFA14A filing, specifically marked as Definitive Additional Materials.

Who is the filing company?

The filing company is USANA HEALTH SCIENCES, INC.

When was this filing submitted?

The filing was submitted on March 27, 2024.

Is there a fee associated with this filing?

No fee is required for this filing.

What is the company's primary business sector?

The company is in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, SIC code 2833.

From the Filing

0001140361-24-015493.txt : 20240327 0001140361-24-015493.hdr.sgml : 20240327 20240327111629 ACCESSION NUMBER: 0001140361-24-015493 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20240327 DATE AS OF CHANGE: 20240327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 24786882 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 DEFA14A 1 ny20017174x2_defa14a.htm FORM DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Mark One) ☒ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to § 240.14a-12   USANA HEALTH SCIENCES, INC.           (Name of Registrant as Specified in its Charter)           (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)   Payment of Filing Fee (Check the appropriate box): ☒ No fee required. ☐ Fee paid previously with preliminary materials. ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays as currently valid OMB control number. GRAPHIC 2 ny20017174x2_na1.jpg begin 644 ny20017174x2_na1.jpg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

View on Read The Filing